君圣泰HTD1801治疗非酒精性脂肪性肝炎（NASH）的临床IIb 期研究（CENTRICITY研究）完成首例患者给药
ROCKVILLE, MD and SHENZHEN, CHINA, Jan 11, 2023 – (亚太商讯 via SEAPRWire.com) – 君圣泰（HighTide Therapeutics Inc.）...
君圣泰完成1.07 亿美元C/C+轮融资，加速推进在研管线的全球开发、商业化和商务拓展
ROCKVILLE, MD and SHENZHEN, CHINA, Jan 5, 2023 – (亚太商讯 via SEAPRWire.com) – 君圣泰（HighTide Therapeutics Inc.）宣...
Virios Therapeutics: The ‘Virus Hypothesis’ That Stands to Change the Lives of 10M Americans
NEW YORK, NY, Aug 9, 2022 – (ACN Newswire via SEAPRWire.com) – PCG Digital — Life may change for the better for the 10 million Americans suffering from fibromyalgia. The […]
Legend Capital’s Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis
HONG KONG, Apr 27, 2022 – (ACN Newswire via SEAPRWire.com) – Legend Capital’s portfolio company Xbiome Inc., an industry-leading and AI-driven microbiome therapeutics company, recently announced that it acquired the […]
Altamira Therapeutics 与 Nuance Pharma 优锐医药签署独家协议，在中国及部分亚洲市场共同开发和商业化Bentrio(TM) 鼻喷剂
Hamilton, Bermuda, Mar 4, 2022 – (亚太商讯 via SEAPRWire.com) – Altamira Therapeutics Ltd. (NASDAQ: CYTO) (简称“Al...
Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets
Hamilton, Bermuda, Mar 4, 2022 – (ACN Newswire via SEAPRWire.com) – Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection […]
Oculis 获Accure Therapeutics授权引进用于治疗青光眼的神经保护候选药物 进一步强化集团的领先眼科产品线
Lausanne, Switzerland, and Barcelona, Spain, Mar 2, 2022 – (亚太商讯 via SEAPRWire.com) – 利用突破性技术和革命性疗法从而改善视力及眼睛...
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics
Lausanne, Switzerland, and Barcelona, Spain, Mar 2, 2022 – (ACN Newswire via SEAPRWire.com) – Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye […]
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries
Cambridge, MA, Feb 16, 2022 – (ACN Newswire via SEAPRWire.com) – Moderna, Inc., (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to expand […]
Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China
FOSTER CITY, Calif. and HANGZHOU, China and HOUSTON, Texas, Feb 11, 2021 – (ACN Newswire) – Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- […]
Fujitsu: Establishment of Joint Venture Aimed at the Development of Therapeutics for the Treatment of Coronavirus Disease
TOKYO, Nov 13, 2020 – (JCN Newswire) – PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (TSE:4587), Fujitsu Limited (TSE:6702), Mizuho Capital Co., Ltd. which is a consolidated subsidiary of Mizuho […]